WYETH PHARMACEUTICALS NAMED TO R&D DIRECTIONS TOP 10 PIPELINE LIST AS 'THE STRONGEST PRIMARY-CARE PIPELINE'
Wyeth Pharmaceuticals, a division of Wyeth , today announced that the R&D
Directions Annual Report of Top 10 Pharmaceutical Pipelines included the Wyeth
pipeline as "The Strongest Primary-Care Pipeline." This is the second
year in a row that Wyeth has been included in the list. In 2004, Wyeth was designated
"The Pipeline to Watch."